Direct Rx: Drug Recall
Recall #D-0364-2025 · 01/31/2025
Class II: Risk
Recall Details
- Recall Number
- D-0364-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Direct Rx
- Status
- Ongoing
- Date Initiated
- 01/31/2025
- Location
- Dawsonville, GA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 477 bottles.
Reason for Recall
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Product Description
CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05.
Distribution Pattern
Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID
Other Recalls by Direct Rx
- Class II: Risk 03/07/2025
- Class II: Risk 03/07/2025
- Class II: Risk 08/09/2024
- Class II: Risk 03/22/2023
- Class II: Risk 03/22/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.